In addition, the weight loss in T2DM patients after the DAPA treatment could have been caused by the increase in ZAG plasma levels which is a well known lipolytic agent and a lipid mobilizing factor3, 20. Here, AZGP1 is linked to type 2 diabetes mellitus.